「arm」の検索結果

Queries PharmGKB / CPIC / DPWG for drug-gene interactions; calls CYP2D6/CYP2C9/CYP2C19/DPYD/TPMT/NUDT15/UGT1A1/SLCO1B1 star alleles and phenotype with PharmCAT, Cyrius (CYP2D6 structural variants), Aldy, Stargazer; applies Caudle 2020 activity-score translation. Use when implementing pharmacogenomic-guided prescribing, applying CPIC vs DPWG guidance, screening HLA risk alleles for ICI / antiepileptics / abacavir, or interpreting compound TPMT+NUDT15 thiopurine risk.

日本語の概要は準備中です。原文の説明を表示しています。

Queries PharmGKB / CPIC / DPWG for drug-gene interactions; calls CYP2D6/CYP2C9/CYP2C19/DPYD/TPMT/NUDT15/UGT1A1/SLCO1B1 star alleles and phenotype with PharmCAT, Cyrius (CYP2D6 structural variants), Aldy, Stargazer; applies Caudle 2020 activity-score translation. Use when implementing pharmacogenomic-guided prescribing, applying CPIC vs DPWG guidance, screening HLA risk alleles for ICI / antiepileptics / abacavir, or interpreting compound TPMT+NUDT15 thiopurine risk.

日本語の概要は準備中です。原文の説明を表示しています。

The Platform List: Arman's own register of large platform-level work he chose not to start yet. Use when the reminder hook says a row is due, when Arman says to add, snooze, kill, or finish a row, when you own a row, or when you think something belongs there. NOT for ordinary tasks, defects, or handoffs.

日本語の概要は準備中です。原文の説明を表示しています。

Treat tokens as a coding swarm's cost-of-goods-sold and legibility engine while accounting for finite subscription allowance when per-call price is unknown. Covers provider windows, remaining-usage evidence, burn forecasts, preemptive checkpoint/model switching, per-agent budgets, compaction, shared digests, context degradation, and spend metering. Activate on: "token budget", "context budget", "compaction strategy", "briefing as compression", "context rot", "summarization collapse", "COGS for agents", "subscription usage remaining", "five-hour or weekly limit", "burn forecast", "model switch before limit", or "/context-economics-for-agent-swarms". NOT for: memory architecture (use always-on-agent-architecture), single-prompt wording (use prompt-engineer), mechanism-design proofs (use nisan-et-al-2007-algorithmic-game-theory), physical containment (use sandboxed-adversarial-test-harness), or production rebodiment and fencing (use agent-resurrection-and-body-continuity).

日本語の概要は準備中です。原文の説明を表示しています。

Add Agent Swarm (Teams) support to Telegram. Each subagent gets its own bot identity in the group. Requires Telegram channel to be set up first (use /add-telegram). Triggers on "agent swarm", "agent teams telegram", "telegram swarm", "bot pool".

日本語の概要は準備中です。原文の説明を表示しています。

Eight SleepのPodの状態確認や電源・温度調整をエージェントに頼めるスキル。アラームとスケジュールの管理、音声再生やベースの角度操作にも対応します。

• Podの状態確認と電源操作
• Podの温度を調整したいとき
• アラームの一覧確認・作成・解除

Advanced swarm orchestration patterns for research, development, testing, and complex distributed workflows

日本語の概要は準備中です。原文の説明を表示しています。

Agent skill for coordinator-swarm-init - invoke with $agent-coordinator-swarm-init

日本語の概要は準備中です。原文の説明を表示しています。

Agent skill for multi-repo-swarm - invoke with $agent-multi-repo-swarm

日本語の概要は準備中です。原文の説明を表示しています。

Agent skill for code-review-swarm - invoke with $agent-code-review-swarm

日本語の概要は準備中です。原文の説明を表示しています。

Run a ruflo swarm agent on the user's own ruOS cloud desktop through the tenant-authenticated fleet MCP, stream its output, and record it in ruflo's swarm state. Use when the user wants an agent to run on a ruOS desktop, asks to "run this on my ruOS desktop", or places a swarm agent on a remote ruOS host.

日本語の概要は準備中です。原文の説明を表示しています。

Anthropic's method for training harmless AI through self-improvement. Two-phase approach - supervised learning with self-critique/revision, then RLAIF (RL from AI Feedback). Use for safety alignment, reducing harmful outputs without human labels. Powers Claude's safety system.

日本語の概要は準備中です。原文の説明を表示しています。

Google Model Armor: Sanitize a user prompt through a Model Armor template.

日本語の概要は準備中です。原文の説明を表示しています。

Google Model Armor: Create a new Model Armor template.

日本語の概要は準備中です。原文の説明を表示しています。

Google Model Armor: Sanitize a model response through a Model Armor template.

日本語の概要は準備中です。原文の説明を表示しています。

Anthropic's method for training harmless AI through self-improvement. Two-phase approach - supervised learning with self-critique/revision, then RLAIF (RL from AI Feedback). Use for safety alignment, reducing harmful outputs without human labels. Powers Claude's safety system.

日本語の概要は準備中です。原文の説明を表示しています。

Submit compact PharmGKB API requests for genes, variants, clinical annotations, dosing guidelines, and search. Use when a user wants concise PharmGKB summaries

日本語の概要は準備中です。原文の説明を表示しています。

Track which of your LinkedIn comments earned author replies. Flags the 6-24h warm-reply window where thread momentum peaks, classifies threads as hot/warm/cool/dormant, and routes warm ones to linkedin-reply-handler for follow-up drafts. Powered by Apify, no LinkedIn login. Triggers on "what threads need follow-up", "author replied", "monitor my comments". Not for analyzing likers on a post (use linkedin-engager-analytics).

日本語の概要は準備中です。原文の説明を表示しています。

Advanced swarm orchestration patterns for research, development, testing, and complex distributed workflows

日本語の概要は準備中です。原文の説明を表示しています。

Cloud-based AI swarm deployment and event-driven workflow automation with Flow Nexus platform

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete reference-grounded single-drug adverse-effect network-pharmacology research designs from a user-provided drug, adverse event, and desired evidence depth. Always use this skill when a user wants to design, plan, or upgrade a conventional network-pharmacology study centered on one fixed drug and one fixed adverse-effect endpoint, using drug-target prediction, adverse-event target collection, overlap analysis, PPI hub prioritization, enrichment interpretation, molecular docking, and optional orthogonal transcriptomic or literature validation. Covers five study patterns (canonical hub-first, cardiotoxicity or electrophysiology-oriented, immune-inflammatory adverse effect, organ-toxicity pathway context, translational validation) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with a recommended primary plan, dependency/evidence map, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, verified-reference pack, and self-critical risk review.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete reference-grounded single-drug adverse-effect network-pharmacology research designs from a user-provided drug, adverse event, and desired evidence depth. Always use this skill when a user wants to design, plan, or upgrade a conventional network-pharmacology study centered on one fixed drug and one fixed adverse-effect endpoint, using drug-target prediction, adverse-event target collection, overlap analysis, PPI hub prioritization, enrichment interpretation, molecular docking, and optional orthogonal transcriptomic or literature validation. Covers five study patterns (canonical hub-first, cardiotoxicity or electrophysiology-oriented, immune-inflammatory adverse effect, organ-toxicity pathway context, translational validation) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with a recommended primary plan, dependency/evidence map, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, verified-reference pack, and self-critical risk review.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete FAERS-style pharmacovigilance disproportionality research designs from a user-provided drug class, comparator strategy, adverse-event domain, and patient-group stratification. Always use this skill whenever a user wants to design, plan, or build a spontaneous-report safety signal study using FAERS or a similar pharmacovigilance database, especially when the article logic includes product selection, indication-group stratification, MedDRA-based adverse-event extraction, serious-case filtering, suspect-drug and concomitant-exclusion logic, reporting odds ratio analysis, comparator-drug benchmarking, cross-drug comparison, and cautious signal interpretation without causal overclaiming. Covers five study patterns (single-drug disproportionality workflow, multi-drug class comparison workflow, indication-stratified workflow, comparator-controlled signal screening workflow...

日本語の概要は準備中です。原文の説明を表示しています。

Fan out N parallel workers, drain them, and return one report. Use for /swarm, 'swarm this', or parallel coverage, races, gauntlets, and exploration.

日本語の概要は準備中です。原文の説明を表示しています。